- Home
- TLSI vs VRA Comparison
TLSI vs VRA Comparison
Compare TLSI & VRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- VRA
- Stock Information
- Founded
- TLSI 2010
- VRA 1982
- Country
- TLSI United States
- VRA United States
- Employees
- TLSI N/A
- VRA N/A
- Industry
- TLSI Medical Specialities
- VRA Apparel
- Sector
- TLSI Health Care
- VRA Consumer Discretionary
- Exchange
- TLSI Nasdaq
- VRA Nasdaq
- Market Cap
- TLSI 204.0M
- VRA 61.7M
- IPO Year
- TLSI N/A
- VRA 2010
- Fundamental
- Price
- TLSI $5.04
- VRA $2.46
- Analyst Decision
- TLSI Strong Buy
- VRA Strong Buy
- Analyst Count
- TLSI 5
- VRA 2
- Target Price
- TLSI $10.90
- VRA $4.00
- AVG Volume (30 Days)
- TLSI 155.6K
- VRA 679.9K
- Earning Date
- TLSI 08-13-2025
- VRA 06-11-2025
- Dividend Yield
- TLSI N/A
- VRA N/A
- EPS Growth
- TLSI N/A
- VRA N/A
- EPS
- TLSI N/A
- VRA N/A
- Revenue
- TLSI $32,141,000.00
- VRA $355,671,000.00
- Revenue This Year
- TLSI $55.52
- VRA N/A
- Revenue Next Year
- TLSI $54.76
- VRA $3.80
- P/E Ratio
- TLSI N/A
- VRA N/A
- Revenue Growth
- TLSI 46.20
- VRA N/A
- 52 Week Low
- TLSI $3.50
- VRA $1.71
- 52 Week High
- TLSI $6.04
- VRA $6.99
- Technical
- Relative Strength Index (RSI)
- TLSI 45.84
- VRA 56.56
- Support Level
- TLSI $4.78
- VRA $2.35
- Resistance Level
- TLSI $5.20
- VRA $2.62
- Average True Range (ATR)
- TLSI 0.31
- VRA 0.18
- MACD
- TLSI -0.03
- VRA 0.03
- Stochastic Oscillator
- TLSI 30.29
- VRA 73.77
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About VRA Vera Bradley Inc.
Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.